Generics Driving Demand for Advanced Superdisintegrants
The expansion of the generics market is not only increasing access to affordable medications—it’s also transforming pharmaceutical manufacturing. Orally disintegrating tablets have become a staple in generics, and superdisintegrants are the silent workhorses that enable their functionality. With a CAGR of 25%, this market’s pace is one to watch. Companies focusing on cost-efficient, high-performance disintegrants will likely lead the charge in this dynamic and rapidly evolving segment.
To Get a PDF Sample Copy of the Report, visit @ https://www.emergenresearch.com/request-sample/4308
5 Views